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Abstract
Many algae have important secretions which are generally used for defensive purposes. These
secretions have caught the attention of a number of researchers, as to whether or not these metabo-
lites can be used in medical research. Among these metabolites, caulerpenyne (CYN) which is the
main metabolite of the Caulerpa species, has had an important place in Caulerpa research since the
beneficial effects related to its determined properties (such as cytotoxic, antiviral, antiproliferative
and apoptotic) have been demonstrated in many scientific reports. In the present study, the inhibito-
ry effect of CYN isolated from C. prolifera on alpha-amylase was investigated. The inhibition exper-
iments were done with CYN by a spectrophotometric determination method. In order to evaluate
the type of inhibition a Lineweaver–Burk plot was produced. The results obtained from enzyme
kinetic studies exhibited a non-competitive type of inhibition, which is characterized by the differ-
ence of Vmax and KM from those of the free enzyme, of alpha-amylase in the presence of CYN. The
present study showed that Caulerpa species may be a potential target for the  production of diabetic
drugs in the light of the results obtained for CYN.
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Introduction
Alpha-Amylase (·-1,-glucan-4-glu-
canohydrolase; EC. 3.2.1.1) is an enzyme
which is related to carbohydrate metabo-
lism and breaks starch down into maltose
and dextrin. A metabolic disorder of this
system, caused by the lack of insulin se-
cretion or activity, results in illness, main-
ly diabetes mellitus, which is characterised
by an increased blood glucose level (ALI
et al., 2006; BHANDARI et al., 2008). An
increased level of glucose in the blood can
damage some of the body’s systems, such
as the blood vessels and the nerves (MATSUI
et al., 2007). According to a WHO research,
5% of the world population are under threat
from this condition (WHO, 2002;
BHANDARI et al., 2008). Due to the im-
portance of the problem drawn attention
to by the WHO, there has been a great
interest among researchers in finding safer
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and more effective drugs. However, the
treatment of diabetes without producing
any side effects is still a problem in the phar-
maceutical industry (CHAKRABORTY
AND RAJAGOPALAN, 2002). One of the
therapeutic approaches for dealing with di-
abetes (ALI et al., 2006; BHANDARI et
al., 2008; FRED-JAIYESIMI et al., 2009)
is decreasing the absorption of glucose from
digestive tract. Thus, inhibition of carbo-
hydrate-hydrolysing enzymes such as alpha-
amylase is very important for the treatment
of diabetes, obesity (OCTIVIO & RIGDEN,
2000; HEIDARI et al., 2005) and the as-
sociated secondary symptoms like arterial
hypertension and cardiovascular disease
(SEGURA & RUILOPE, 2006). Nowa-
days, acarbose, voglibose and miglitol are
generally used for this purpose, but they
can cause several side effects, such as ab-
dominal distension, bloating, flatulence and
diarrhoea (CHAKRABARTI & RAJAGO-
PALAN, 2002; KIMMEL & INZUCCHI,
2005; FRED-JAIYESIMI et al., 2009). Th-
ese side effects can be explained due to the
fermentation of carbohydrates in the colon
which they are able to reach as a result of
the complete inhibition of alpha-amylase
(BISCHOFF, 1994). In addition, it is thought
that some of these drugs may increase the
incidence of renal tumours, hepatic in-
jury and acute hepatitis (SHOBANA et al.,
2009). 
In the light of the knowledge mentioned
above, it is necessary to find efficient in-
hibitors with minimum side effects, and es-
pecially to take them from the natural sources.
Various resources have been analysed in
order to find a remedy for diabetes (ALI et
al., 2006; BHANDARI et al., 2008;
CHETHAN et al., 2008; LOIZZO et al.,
2008; AGUILAR-SANTAMAR A et al.,
2009; FRED-JAIYESIMI et al., 2009;
SHOBANA et al., 2009). It has been re-
ported that some of the compounds relat-
ed to the defence mechanisms of plants may
act as an inhibitors of hydrolytic enzymes
such as alpha-amylase (FARIAS et al., 2007). 
In the present study, the main second-
ary metabolite from the Caulerpa species,
caulerpenyne (CYN), was selected, in or-
der to evaluate its potential for the treat-
ment of diabetes. Several researchers have
already focused on observing the chemi-
cal effects of CYN: the cytotoxic effects on
sea urchins (LEMÉE et al., 1993; GALGANI
et al., 1996), antiviral effects on feline im-
munodeficiency virus (FIV) (NICOLETTI
et al., 1999), antiproliferative effects on SK-
N-SH cell lines (BARBIER et al., 2001) and
on eight human cancer cell lines (FISCHEL
et al., 1995) have been reported. The an-
tiproliferative and apoptotic effects were
also shown by CAVAS et al. (2006). How-
ever, there are few studies in the litera-
ture in which the enzyme inhibitory poten-
tial of CYN and crude extracts of Caulerpa
species are evaluated. It has been reported
that the methanolic extract of C. taxifolia
and CYN inhibit pancreatic lipase activity
(BITOU et al., 1999). The inhibition of li-
pase activity was also shown by the ethano-
lic extract of C. prolifera (REBAH et al.,
2008). The inhibitory activity of CYN puri-
fied from C. prolifera was revealed by
MAYER et al. (1993). NINOMIYA et al.
(1998) have shown that the active metabo-
lite of ethyl acetate extracts of C. taxifolia,
which is responsible for 12-LOX inhibition
is a CYN derivative. Although alpha-amy-
lase inhibition via acetone crude extract
of C. racemosa has been reported (TEIXERIA
et al., 2007), there is no information about
the type of inhibition. Because TEIXERIA
et al. (2007) did not perform any inhibition
kinetic experiments, we aimed to elucidate
the type of inhibition as a result of kinetic
studies.  
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Material and Methods  
Caulerpenyne determination in C. prolifera
C.prolifera (Forssk l) J.V. Lamouroux  was
collected from the e me coastline described
with the coordinates of 38Æ 07' 56 82" N -
26Æ 50' 06 72" E in May 2009. The algae
were transported to the laboratory imme-
diately to prevent CYN transformation
into aldehydes (JUNG et al., 2002) and were
used as a source of CYN. In order to eval-
uate the amount of CYN in fresh material,
the procedures described by BOX et al.,
(2008) were applied. Preparation of crude
methanolic extract was followed by filter-
ing it on SepPack columns. The CYN com-
ponent was eluted with a mixture of
methanol:ethyl acetate 50:50. The concen-
tration of CYN was determined with HPLC
by comparing the results with a calibration
curve that was obtained by using known con-
centrations of standard CYN. 
Isolation of CYN from C. prolifera
In order to prevent the enzymatic degra-
dation of CYN described in JUNG et al.
(2002), the fresh alga was extracted with
ethyl acetate under liquid nitrogen. The pu-
rified CYN was obtained after successive
elutings from two silica gel columns using
the mixtures of petroleum ether:ethyl ac-
etate (7:3) and petroleum ether:diethyl ether
(6:4) respectively as eluents. In order to de-
termine the purity of CYN, it was tested by
using reverse phase HPLC and 1H NMR
spectroscopy. 1H NMR data were identical
with those reported in the literature (AMICO
et al., 1978). 
Alpha-Amylase activity assay for inhibition
tests of CYN
Alpha-Amylase from bacillus species
(EC. 3.2.1.1, Type II A) and starch were
purchased from Sigma Chemical Co., St.
Louis, USA and Merck & Co., Inc, re-
spectively. The ·-amylase inhibition assay
was performed according to the chromogenic
method adopted by Sigma–Aldrich, adapt-
ed from BERNFELD (1951). The activi-
ty was detected by using a starch (1%) so-
lution in a 20 mM phosphate buffer (pH
6.9) containing 6.7 mM sodium chloride as
a substrate. The enzyme solution was pre-
incubated with different concentrations of
CYN (1:1 ratio) for 10 mins. and 30 mins.
at 37ÆC to obtain the optimum conditions
and 30 mins. was determined as the opti-
mum pre-incubation time for the enzyme-
inhibitor mixture. 100 ÌL of enzyme solu-
tion (pre-incubated) was added to 100 ÌL
of starch solution. Then, the reaction was
stopped by adding a two-fold dinitrosali-
cylic acid solution (DNS) and boiled for 5
mins. in a boiling water bath. After cooling
the mixture, 2 mL of distilled water was
added and the enzyme activity was deter-
mined by measuring the maltose equiva-
lents released from starch at 540 nm. All
experiments were performed in two repli-
cations and the solvent controls were made.
Enzyme inhibition kinetics
The mode of inhibition was determined
by using Michaelis-Menten and Line-
weaver–Burk equations. Enzyme activi-
ties were investigated in the absence or pres-
ence of different concentrations of CYN
(0.25 mM, 0.75 mM and 1 mM). Various
concentrations of starch solution (0.25-2.5 %)
were used as a substrate. All experiments
were performed in two replications and the
results were expressed as mean ± S.D. 
Results
In order to determine the amount of
the main secondary metabolite of the Cauler-
pa species, CYN, HPLC analyses were per-
s
a
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formed with a crude extract of C. prolif-
era, which was prepared according to pro-
cedures described by BOX et al., (2008).
The CYN content of C. prolifera was found
as 6.34 mg/g wet weight of algae by using
the HPLC method (Fig. 1). 
Since the type of inhibition can be pre-
dicted according to the shape of the
Lineweaver–Burk plot, this plot was pro-
duced (Fig. 2). The results calculated from
this plot revealed a non-competitive type
inhibition effect on alpha-amylase, due to
the different KM and Vmax values from those
of the control sample (free enzyme). The
control sample values were 3333 Ìmol malt-
ose/mg protein.min and 10 % for Vmax and
KM, respectively. The counterparts of these
values in the presence of different con-
centrations of CYN are shown in Table 1.
The inhibitory constants (KI) of CYN
on the alpha-amylase enzyme activity were
calculated by using the graphs which were
plotted according to the two equations be-
low (Fig. 3,  Fig. 4):
(1)
(2)
where Vmax represents the maximum velocity
of the reaction, KM is the Michaelis-Men-
ten constant, [I] is the inhibitor concen-
tration, KI is the dissociation constant for
binding of an inhibitor to the enzyme-sub-
strate complex, Vmax.app and Km.app are the
apparent Vmax and KM values. KI values were
determined respectively as 0.41 mM and
0.42 mM from these graphs.
Medit. Mar. Sci., 11/1 2010, 93-10396
Fig. 1: The chromatograms of HPLC analyses with UV detection of methanolic extracts from Cauler-
pa prolifera. a) 5 ppm CYN with 25 ppm internal standart (4-methoxyacetophenone). b) C. prolifera
extract. Conditions: HPLC with a reverse-phase (3 ÌM) column (15 x 0.4 cm) (Teknokroma), eluted
with water:metanol (20:80, v:v) at a flow-rate of 0.4 mL/min and with UV detection at 254 nm.
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Table 1
Kinetic properties of alpha-amylase.
CYN concentration Vmax (Ìmol maltose/mg protein.min) KM (%)
0 mM 3333 10.0
0.25 mM 357 1.1
0.75 mM 250 0.8
1 mM 169 0.5
Fig. 2: Lineweaver–Burk plot of alpha-amylase (96 U/mL) reaction with variable starch concentra-
tions in the absence or presence of CYN.  Starch concentrations change between 0.25 % - 2.5 %.
The values represent the mean ± standard deviation of two independent experiments.
Fig. 3: 1/Vmapp – Inhibitor concentration plot related to Equation 1.
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Discussion
The main secondary metabolite of the
Caulerpa species was identified as CYN; it
is known that the quantity of this metabo-
lite changes depending on many factors,
such as season, temperature, depth, stress
conditions, etc (AMADE & LEMEE, 1998;
SUREDA et al., 2009). As a result of its
unique properties, such as antiproliferative
and apoptotic effects against some neu-
roblastoma, tumor and cancer cell lines
(CAVAS et al., 2006; FISCHEL et al., 1995;
BARBIER et al., 2001) and antiviral prop-
erties (NICOLETTI et al., 1999), LOX in-
hibition (NINOMIYA et al., 1998), PLA2
inhibition (MAYER et al., 1993), lipase in-
hibition (BITOU et al., 1999; REBAH et
al., 2008) and alpha-amylase inhibition
(TEIXEIRA et al., 2007) a great deal of
research has been done. The CYN content
in C. prolifera was found to be 6.34 mg/g
wet weight of algae by using an HPLC
method. This result is well in line with the
results described by JUNG et al., (2002).
JUNG et al. (2002) proposed a new method
for determining CYN which underlines that
freezing the algae material before extrac-
tion is better than freezing after solvent ad-
dition to prevent CYN degradation.
There is a great interest in natural sources
regarding their use in medical research.
Plants in particular have an important po-
sition in the area of medical research. More
than 1123 plant species have been identi-
fied in the treatment of diabetes by GROVER
et al. (2002), and also more than 200 pure
compounds have a significant effect  on the
lowering of glucose in the blood (MARLES
& FARNSWORTH, 1994). The compounds
with an inhibitory effect on alpha-amylase
enzymic activity are presented in Table 2.
ALI et al. (2006) investigated the in-
hibitory effects of certain Malaysian plants
on alpha-amylase and they only found one
as promising material for lowering the glu-
cose level. They showed that the hexane ex-
tract of Phyllanthus amarus caused a sig-
nificant inhibition of the enzyme with IC50
value of value of 32 µg/mL. The in vitro an-
ti-diabetic effect of the Nepalese medicinal
herb Pakhanbhed (Bergenia ciliata, Haw.)
was investigated, as it has been used to treat
diabetes since prehistoric times (BHANDARI
et al., 2008). Both the crude methanolic ex-
tract of this species and the two active com-
Medit. Mar. Sci., 11/1 2010, 93-10398
Fig. 4: 1/Kmapp – Inhibitor concentration plot related to Equation 2.
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pounds identified as (-)-3-O-galloylepicat-
echin and (-)-3-O-galloylcatechin showed
significant inhibition in a dose dependent
manner on alpha-amylase. The IC50 val-
ues were determined as 739 ÌM and 401 ÌM
for (-)-3-O-galloylepicatechin and (-)-3-
O-galloylcatechin, respectively. The anti-
diabetic activity of the Spondias mombin
leaf was demonstrated by FRED-JAIYESIMI
(2009). S. mombin is traditionally used for
the treatment of various diseases such as di-
abetes, intestinal disorders and fever. In the
latter study, it was shown that the most
active inhibitory fraction was obtained with
diethyl ether and this fraction showed 73%
inhibition on Aspergillus oryzae alpha-amy-
lase at 70 mg/mL. Moreover, an active com-
pound isolated from this species, 3‚-olean-
12-en-3-yl (9Z)-hexadec-9-enoate, presented
57% inhibition on alpha-amylase at the con-
centration of 20 mg/mL. LOIZZO et al.
(2008) investigated the alpha-amylase in-
hibitory activities of nine plant species
traditionally used against diabetes. It was
demonstrated that Marrubium radiatum and
Salvia acetabulosa showed the highest in-
hibitory activity against alpha-amylase with
the IC50 values of 61.1 Ìg/mL and 91.2 Ìg/mL,
respectively. The present investigation took
place in the light of the study which was con-
ducted by TEIXEIRA et al. (2007) for de-
termining the inhibitory effect of Cauler-
pa extracts on alpha–amylase. They reported
that a crude acetone extract of C. racemosa
has a strong alpha-amylase inhibition effect
with an ED50 of 0.09 mg/mL. Although a
Caulerpa species was used as a source of in-
hibitory material, there were no kinetic de-
tails in this report. According to our results,
the alpha-amylase inhibition with CYN rep-
resents a non-competitive type of inhibition
in consequence of the different KM and Vmax
values from those of the control sample (free
enzyme). SHOBANA et al. (2009) investi-
gated the inhibitory effects of phenolic com-
pounds of Eleusine coracana L. on alpha-
glucosidase and pancreatic amylase. The
results obtained from the Lineweaver–Burk
plot showed that phenolics exhibited a non-
competitive inhibition of pancreatic amy-
lase. This type of inhibition was also re-
ported for Rhus chinensis extract (SHIM et
al., 2003). CHETHAN et al. (2008) deter-
mined the effect of millet polyphenols on
alpha-amylase. They stated that the type of
the inhibition was mixed non-competitive,
which was represented by the decrease in
Vmax values while the KM was constant.
Although the polyphenol extracts caused
mixed non-competitive inhibition on alpha-
amylase, the pure compounds isolated from
the polyphenol extract such as gallic acid,
vanillic acid, quercetin and trans-cinnam-
ic acid induced non-competitive inhibition.
In the light of this study, quercetin was al-
so used as a known inhibitor for alpha-amy-
lase and the non-competitive type of inhi-
bition was determined in the present study
(data not shown). 
Conclusion
The present study demonstrates that
CYN inhibits alpha-amylase activity in a
dose dependent manner. According to
the results of this study CYN may be used
for developing therapeutic agents, but
further studies need to be performed. Since
amylases play a significant role in diabetes,
obesity and other related diseases, Cauler-
pa species-derived metabolites can be prom-
ising material for the treatment of these ill-
nesses. 
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